Active induction of experimental allergic encephalomyelitis. (Q48175463)

9 February 2018

title

Active induction of experimental allergic encephalomyelitis. (English)

1 reference

9 February 2018

author name string

Ingunn M Stromnes

series ordinal

1

1 reference

9 February 2018

Joan M Goverman

series ordinal

2

1 reference

9 February 2018

publication date

1 January 2006

1 reference

9 February 2018

published in

Nature Protocols

1 reference

9 February 2018

volume

1

1 reference

9 February 2018

page(s)

1810-1819

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/nprot.2006.285

exact match

0 references

cites work

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Transgenic models to study the actions of cytokines in the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Mechanisms of immunopathology in murine models of central nervous system demyelinating disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The T lymphocyte in experimental allergic encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Transfer of allergic encephalomyelitis in rats by means of lymph node cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Acute disseminated encephalomyelitis produced in mice by brain proteolipide (Folch-Lees).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Proteins and glycoproteins in plasma membranes and in the membrane lamellae produced by purified oligodendroglia in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Tentative identification of a second central nervous system myelin membrane autoantigen (M2) by a biochemical comparison with the basic protein (BP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Immune tolerance to myelin proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Passive induction of experimental allergic encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Modelling of multiple sclerosis: lessons learned in a non-human primate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Fc Receptors are Critical for Autoimmune Inflammatory Damage to the Central Nervous System in Experimental Autoimmune Encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Mapping and identification of autoimmunity genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Current gene-mapping strategies in experimental models of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Enhancement of experimental autoimmune encephalomyelitis severity by ultrasound emulsification of antigen/adjuvant in distinct strains of mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Regulatory T cells in spontaneous autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Regulation of autoreactive T cell function by oral tolerance to self-antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The value of animal models for drug development in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The effects of citrullination or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The role of CD8(+) T cells in multiple sclerosis and its animal models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Delayed, relapsing experimental allergic encephalomyelitis in mice. Role of adjuvants and pertussis vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Self-determinants in autoimmune demyelinating disease: changes in T- cell response specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Screening of several H-2 congenic mouse strains identified H-2q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell r

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.285

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPROT.2006.285

1 reference

9 February 2018

PubMed ID

17487163

1 reference

9 February 2018